- Berical, A.C., Harris, D., Dela Cruz, C.S. and Possick, J.D. (2016). Pneumococcal Vaccination Strategies an Update and Perspective. Annals of American Thoracic Society, 13(6): 933-944.
- Borsa, N., Pasquale, M.D. and Restrepo, M.I. (2019). Animal Models of pneumococcal pneumonia. International Journal of Molecular Science, 20(17): 4222.
- Chanter, N. (1997). Streptococci and enterococci as animal pathogens. Journal of Applied Microbiology Symposium Supplement, 83(S1): 100S-109S.
- Chiavolini, D., Pozzi, G. and Ricci, S. (2008). Animal models of Streptococcus pneumonia Disease. Clinical Microbiology Reviews, 21(4): 666-685.
- Converso, T.R., Assoni, L., André, G.O., Darrieux, M. and Leite, L.C.C. (2020). The long search for a serotype independent pneumococcal vaccine. Expert Review of Vaccines, 19(1): 57-70.
- Daniels, C.C., Rogers, P.D. and Shelton, C.M. (2016). Review of pneumococcal vaccines: Current polysaccharide vaccine recommendations and future protein antigenes. The Journal of Pediatric Pharmacology and Therapeutics, 21(1): 27-35.
- Dockrell, H.D., Whyte Moira, M.K.B. and Timothy, J.M. (2012). Pneumococcal pneumonia mechanisms of infection and resolution. Chest, 142(2): 482-491.
- Feldman, C. and Anderson R. (2020). Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000 Research, 7(9): F1000.
- Gestur, V., Ingileif, J., Steinn, J. and Helgi, V. (1994). Opsonization and antibodies to capsular and cell wall polysaccharide of Streptococcus pneumoniae. The Journal of Infectious Diseases, 170(3): 592-599.
- Ginders, M., Leschnik, M., Künzel, F., Kampner, D., Mikula, C., Steindl, G., et al. (2017). Characterization of Streptococcus pneumoniae isolates from Austrian companion animals and horses. Acta Veterinaria Scandinavica, 59(1): 79.
- Jia, P., Dai, S., Wu, T. and Yang, S. (2021). New approaches to anticipate the risk of reverse zoonosis, 36(7): 580-590.
- Martinez, J.E., Clutterbuck, E.A., Li, H., Romero-Steiner, S. and Carlone, G.M. (2006). Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clinical and Vaccine Immunology, 13(4): 459-466.
- Martinez, J.E., Romero-Steiner, S., Pilishvili, T., Barnard, S., Schinsky, J., Goldblatt, D., et al. (1999). A flowcytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with 23-valent pneumococcal polysaccharide vaccine. Clinical and Diagnostic Laboratory Immunology, 6(4): 581-586.
- Masomian, M., Ahmad, Z., Gew, L.T. and Poh, C.L. (2020). Development of next generation Streptococcus pneumoniae vaccines conferring broad protection. Vaccines (Basel), 17; 8(1): 132.
- Nau, R., Kaye, K., Sachdeva, M., Sande, E. and Tauber, M.G. (1994). Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial Agents and Chemotherapy, 38: 1186-1189.
- Papadatou, I., Tzovara, I. and Licciardi, P.V. (2019). The role of serotype-specific immunological memory in pneumococcal vaccination: Current knowledge and future prospects. Vaccines, 7(1): 13.
- Park, C., Kwon, E.Y., Choi, S.M., Cho, S.Y., Byun, J.H., Park, J.Y., et al. (2017). Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model. Human Vaccines & Immunotherapeutics, 13(5): 1169-1176.
- Robert, L.B. and Moon, H.N. (2006). Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clinical and Vaccine Immunology, 13(9): 1004-1009.
- Romero-Steiner, S., Frasch, C., Concepcion, N., Goldblatt, D., Kayhty, H., Vakevainen, M., et al. (2003). Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clinical and Diagnostic Laboratory Immunology, 10(6): 415-422.
- Saeland, E., Vidarsson, G. and Jonsdottir, I. (2000). Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies. Microbial Pathogenesis, 29(2): 81-91.
- Soheyli, Z., Soleimani, M. and Majidzadeh, K. (2017). A PCR Assay for detection of mycoplasma contamination in cell culture by rRNA 16S specific primers. Paramedical Sciences and Military Health, 12(2): 13-20. [In Persian]
- Sorensen, R.U. and Edgar, D. (2019). Specific antibody deficiencies in clinical practice. The Journal of Allergy and Clinical Immunology: In Practice, 7(3): 801-808.
- Stern, P.L. (2020). Key steps in vaccine development. Annals of Allergy, Asthma & Immunology, 125(1): 17-27.
- Timoney, J.F. (2004). The pathogenic equine streptococci. Veterinary Research, 35(4): 397-409.
- Turner, A.E.B., Gerson, J.E., So, H.Y., Krasznai, D.J., Hilaire, A.J.S. and Gerson, D.F. (2017). Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumonia. Synthetic and Systems Biotechnology, 2(1): 49-58.
- Whatmore, A.M., King, S.J., Doherty, N.C., Sturgeon, D., Chanter, N. and Dowson, C.G. (1999). Molecular characterization of equine isolates of Streptococcus pneumoniae: natural disruption of genes encoding the virulence factors pneumolysin and autolysin. Infection and Immunity, 67(6): 2776-2782.
- Woudenberg, I.A., Hoenderop, J.Y. and Michel, M.F. (1979). Efficacy of antimicrobial chemotherapy in experimental rat pneumonia: effects of impaired phagocytosis. Infection and Immunity Journal, 25(1): 366-375.
|
